Mitochondrial Unfolded Protein Response and Integrated Stress Response as Promising Therapeutic Targets for Mitochondrial Diseases

Cells. 2022 Dec 21;12(1):20. doi: 10.3390/cells12010020.

Abstract

The development and application of high-throughput omics technologies have enabled a more in-depth understanding of mitochondrial biosynthesis metabolism and the pathogenesis of mitochondrial diseases. In accordance with this, a host of new treatments for mitochondrial disease are emerging. As an essential pathway in maintaining mitochondrial proteostasis, the mitochondrial unfolded protein response (UPRmt) is not only of considerable significance for mitochondrial substance metabolism but also plays a fundamental role in the development of mitochondrial diseases. Furthermore, in mammals, the integrated stress response (ISR) and UPRmt are strongly coupled, functioning together to maintain mitochondrial function. Therefore, ISR and UPRmt show great application prospects in the treatment of mitochondrial diseases. In this review, we provide an overview of the molecular mechanisms of ISR and UPRmt and focus on them as potential targets for mitochondrial disease therapy.

Keywords: integrated stress response; mitochondrial diseases; mitochondrial function; mitochondrial unfolded protein response.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biological Phenomena*
  • Humans
  • Mammals
  • Mitochondria / metabolism
  • Mitochondrial Diseases* / pathology
  • Unfolded Protein Response

Grants and funding

This research was funded by the National Key R&D Program of China, grant number 2021YFC2700901, the National Natural Science Foundation of China, grant numbers 82001635, 81871216, 81971455 and U20A20350, the Foundation for Selected Scientists Studying Abroad of Anhui Province, grant number 2022LCX015, and Program for Outstanding Young Talents in University of Anhui, grant number gxyqZD2022027.